COVID-19 Hospitalization Outcomes Among Patients With Autoimmune Rheumatic Diseases in the United States.

ABSTRACT:

Objectives

To investigate the outcomes of COVID-19-related hospitalizations among patients with autoimmune rheumatic diseases (ARDs) in the United States in 2020. The primary outcome was in-hospital mortality, and secondary outcomes included intubation rate, length of hospital stay (LOS), and total hospital charges (THCs).

Methods

Data for the study were obtained from the National Inpatient Sample database and included patients who were hospitalized with a principal diagnosis of COVID-19. Univariable and multivariable logistic regression analyses were conducted to calculate odds ratios for the outcomes, adjusting for age, sex, and comorbidities.

Results

Out of the 1,050,720 COVID-19 admissions, 30,775 had an ARD diagnosis. The unadjusted analysis showed higher mortali

SUBMITTER: Khalaf A 

PROVIDER: S-EPMC10349215 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature